Renaud Ronald C Jr - Net Worth and Insider Trading

Renaud Ronald C Jr Net Worth

The estimated net worth of Renaud Ronald C Jr is at least $0 dollars as of 2023-03-23. Renaud Ronald C Jr is the CEO of Translate Bio Inc and owns about 0 shares of Translate Bio Inc (TBIO) stock worth over $0. Details can be seen in Renaud Ronald C Jr's Latest Holdings Summary section.

Transaction Summary of Renaud Ronald C Jr


Renaud Ronald C Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renaud Ronald C Jr owns 7 companies in total, including Atara Biotherapeutics Inc (ATRA) , Translate Bio Inc (TBIO) , and Chimerix Inc (CMRX) among others .

Click here to see the complete history of Renaud Ronald C Jr’s form 4 insider trades.

Insider Ownership Summary of Renaud Ronald C Jr

Ticker Comapny Transaction Date Type of Owner
ATRA Atara Biotherapeutics Inc 2021-06-08 director
TBIO Translate Bio Inc 2020-03-03 director & Chief Executive Officer & other: President
CMRX Chimerix Inc 2014-12-17 director
AKBA Akebia Therapeutics Inc 2014-09-12 director
PTCT PTC Therapeutics Inc 2017-01-03 director
KERX Keryx Biopharmaceuticals Inc 2007-02-14 Chief Financial Officer
IKNA Ikena Oncology Inc 2021-03-25 director

Renaud Ronald C Jr Latest Holdings Summary

Renaud Ronald C Jr currently owns a total of 1 stock. Renaud Ronald C Jr owns 0 shares of Translate Bio Inc (TBIO) as of September 14, 2021, with a value of $0.

Latest Holdings of Renaud Ronald C Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TBIO Translate Bio Inc 2021-09-14 0 37.36 0

Holding Weightings of Renaud Ronald C Jr

Renaud Ronald C Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Renaud Ronald C Jr has made a total of 1 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Translate Bio Inc is the sale of 954,053 shares on September 14, 2021, which brought Renaud Ronald C Jr around $36 Million.

Insider Trading History of Renaud Ronald C Jr

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
Translate Bio Inc
Akebia Therapeutics Inc
Total 2
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renaud Ronald C Jr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Renaud Ronald C Jr Ownership Network

Ownership Network List of Renaud Ronald C Jr

No Data

Ownership Network Relation of Renaud Ronald C Jr

Renaud Ronald C Jr Owned Company Details

What does Atara Biotherapeutics Inc do?

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Who are the key executives at Atara Biotherapeutics Inc?

Renaud Ronald C Jr is the director of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Chief Technical Officer Charlene A. Banard , Chief Commercial Officer Kristin Yarema , and SVP & GC & Secretary Amar Murugan .

Atara Biotherapeutics Inc (ATRA) Insider Trades Summary

Over the past 18 months, Renaud Ronald C Jr made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 42,900 shares made by Utpal Koppikar , a net sale of 36,833 shares made by Jakob Dupont , and a net sale of 91,439 shares made by Pascal Touchon .

In summary, during the past 3 months, insiders sold 34,330 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 34,330 shares. During the past 18 months, 214,045 shares of Atara Biotherapeutics Inc (ATRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 214,045 shares.

Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.


NAS:ATRA Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Renaud Ronald C Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Renaud Ronald C Jr. You might contact Renaud Ronald C Jr via mailing address: C/o Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge Ma 02109.